Impax Laboratories (IPXL) Misses Q1 EPS by 2c, Miss on Revenues
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Total operating expenses: 107.2M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Total operating expenses: 107.2M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q1 EPS of $0.11, $0.02 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $184.4 million versus the consensus estimate of $191.25 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
